Table 3.
Interaction between ALDH2 and ADH2 genotype and the ORs for esophageal cancer
ADH2 | ALDH2 | Cases | Controls | OR1 (95% CI) | OR2 (95% CI) |
A/A | G/G | 44 | 68 | 1.00 | 1.00 |
G/A+G/G | G/G | 46 | 46 | 1.55 (0.89-2.70) | 1.46 (0.79-2.70) |
A/A | G/A | 40 | 33 | 1.87 (1.03-3.40) | 1.93 (0.99-3.75) |
G/A+G/G | G/A | 49 | 33 | 2.29 (1.28-4.11) | 2.10 (1.13-3.91) |
A/A | A/A | 22 | 7 | 4.98 (1.91-12.33) | 5.28 (1.88-14.83) |
G/A+G/G | A/A | 20 | 4 | 7.73 (2.48-24.13) | 12.22 (2.62-56.91) |
Crude OR;
ORs were adjusted for income.